Discussion
Non-access
POSTOPERATIVE COMPLICATIONS
The efficacy and safety of PIPAC as a novel treatment for PSMs is still being investigated (Kepenekian et al. C and D were used as chemotherapeutic agents in the PIPAC procedure’s first description (Solaß et al. In accordance with Hübner et al. (Non-access is one of the main factors that limits PIPAC’s repeatability. Reviews by Grass et al. (Anesthesia-related intra- or postoperative complications were also reported by Alyami et al. (The rise in CRP and leucocytes for a few days after PIPAC has been widely observed (Grass et al. Like many studies (Kurtz et al. 